Free Trial
NYSE:MCK

McKesson Q2 2027 Earnings Report

McKesson logo
$908.99 -12.68 (-1.38%)
Closing price 03:58 PM Eastern
Extended Trading
$908.73 -0.25 (-0.03%)
As of 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

McKesson EPS Results

Actual EPS
N/A
Consensus EPS
$10.72
Beat/Miss
N/A
One Year Ago EPS
N/A

McKesson Revenue Results

Actual Revenue
N/A
Expected Revenue
$109.86 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

McKesson Announcement Details

Quarter
Q2 2027
Time
After Market Closes
Conference Call Date
Wednesday, November 4, 2026
Conference Call Time
4:30PM ET

Conference Call Resources

McKesson Earnings Headlines

McKesson, CD&R to Acquire Option Care Health
Here's Why McKesson (MCK) Fell More Than Broader Market
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up Amazon and Netflix under $3 per share in 2005. Now the chief investment strategist at The Oxford Club has identified three AI stocks he believes could be the most profitable investments of the next decade.tc pixel
Is McKesson (MCK) a Solid Growth Stock? 3 Reasons to Think "Yes"
Option Care stock surges on McKesson's home-infusion bet
See More McKesson Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like McKesson? Sign up for Earnings360's daily newsletter to receive timely earnings updates on McKesson and other key companies, straight to your email.

About McKesson

McKesson (NYSE:MCK) (NYSE:MCK) is a healthcare services and information technology company that distributes pharmaceuticals, specialty drugs, medical supplies and other healthcare products. The company serves pharmacies, hospitals, health systems, physician practices, biopharma manufacturers and other healthcare providers, helping move products from manufacturers to patients and care settings.

McKesson’s principal operations include pharmaceutical distribution, medical-surgical supply distribution and technology-enabled services for pharmacies and providers. Its specialty businesses support areas such as oncology and other complex therapies, while its technology and services offerings help customers manage prescriptions, practice operations, patient access and medication-related programs.

Founded in 1833, McKesson has developed from a wholesale drug business into a broad healthcare-services company. Its operations primarily serve customers in the United States, with additional activities in selected international markets. The company is headquartered in Irving, Texas, and is led by President and Chief Executive Officer Brian Tyler.

View McKesson Profile